KIF22 promotes progress of esophageal squamous cell carcinoma cells and is negatively regulated by miR-122.

Wang, Jian; Yu, Peng-Yi; Yu, Jing-Ping; Luo, Ju-Dong; Sun, Zhi-Qiang; Sun, Fei; Kong, Ze; Wang, Jian-Lin.

Afiliação

Wang J; Department of Radiotherapy, Jiangyin People's Hospital Jiangyin 214400, Jiangsu Province, China.
Yu PY; Department of Cardiothoracic Surgery, The Third Affiliated Hospital of Soochow University Changzhou 213003, Jiangsu Province, China.
Yu JP; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University Changzhou 213003, Jiangsu Province, China.
Luo JD; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University Changzhou 213003, Jiangsu Province, China.
Sun ZQ; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University Changzhou 213003, Jiangsu Province, China.
Sun F; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University Changzhou 213003, Jiangsu Province, China.
Kong Z; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University Changzhou 213003, Jiangsu Province, China.
Wang JL; Department of Radiotherapy, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University Changzhou 213003, Jiangsu Province, China.

Am J Transl Res ; 13(5): 4152-4166, 2021.

Article em En | MEDLINE | ID: mdl-34150005